Polymer membranes for continuous analyte sensors
AssigneeDexCom, Inc.
InventorsRobert Boock, Monica Rixman Swinney, Huashi Zhang, Michael J. Estes, Kristina Lawrence
Life of this patent
Estimating the term…
Abstract
Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.
Claims17
A sensor for measurement of an analyte, the sensor comprising:
- an in vivo portion configured to be inserted within a body of a host, the in vivo portion comprising:
- an electrode configured to measure a signal associated with an analyte concentration in the host;
- and
- a membrane located over at least a portion of the electrode, wherein the membrane comprises an enzyme;
- and
- an ex vivo portion configured to remain outside of the body of the host,
- wherein the sensor is configured to be calibrated based on a correlation between an in vivo sensor sensitivity and an in vitro sensor sensitivity;
- wherein the sensor is configured to provide, at analyte concentrations of from 40 mg/dL to 400 mg/dL, a level of accuracy corresponding to a mean absolute relative difference of between 7% to 10% over a sensor session of anywhere between 1 to 30 days, and
- wherein one or more reference measurements associated with calculation of the mean absolute relative difference are determined by analysis of blood.
A sensor for measurement of an analyte, the sensor comprising:
- an in vivo portion configured to be inserted within a body of a host, the in vivo portion comprising:
- an electrode configured to measure a signal associated with an analyte concentration in the host and
- a membrane located over at least a portion of the electrode, wherein the membrane comprises an enzyme;
- and
- an ex vivo portion configured to remain outside of the body of the host,
- wherein the sensor is configured to be calibrated based on a correlation between an in vivo sensor sensitivity and an in vitro sensor sensitivity;
- wherein the sensor is configured to provide, at analyte concentrations of from 40 mg/dL to 400 mg/dL, a level of accuracy corresponding to a mean absolute relative difference of between 5% to 15% over a sensor session of anywhere between 1 to 30 days, and
- wherein one or more reference measurements associated with calculation of the mean absolute relative difference are determined by analysis of blood
- wherein the sensor is configured to provide, at analyte concentrations of from 40 mg/dL to 80 mg/dL, a second level of accuracy corresponding to a second mean absolute relative difference, the mean absolute relative difference being less than the second mean absolute relative difference.
A sensor for measurement of an analyte, the sensor comprising:
- an electrode configured to measure a signal associated with an analyte concentration in a host;
- an enzyme domain;
- and
- a membrane in contact with the enzyme domain, wherein the membrane is located over at least a portion of the electrode, and wherein the membrane configured to reduce a flux of one or more interferents from reaching the enzyme domain,
- wherein the sensor is configured to provide, at analyte concentrations of from 40 mg/dL to 400 mg/dL, a level of accuracy corresponding to a mean absolute relative difference of between 7% to 10% over a sensor session of between 1 to 30 days, and
- wherein one or more reference measurements associated with calculation of the mean absolute relative difference are determined by analysis of blood.
A sensor for measurement of an analyte, the sensor comprising:
- an electrode configured to measure a signal associated with an analyte concentration in a host
- an enzyme domain;
- and
- a membrane in contact with the enzyme domain, wherein the membrane is located over at least a portion of the electrode, and wherein the membrane configured to reduce a flux of one or more interferents from reaching the enzyme domain,
- wherein the sensor is configured to provide, at analyte concentrations of from 40 mg/dL to 400 mg/dL, a level of accuracy corresponding to a mean absolute relative difference of between 5% to 15% over a sensor session of between 1 to 30 days, and
- wherein one or more reference measurements associated with calculation of the mean absolute relative difference are determined by analysis of blood
- wherein the sensor is configured to provide, at analyte concentrations of from 40 mg/dL to 80 mg/dL, a second level of accuracy corresponding to a second mean absolute relative difference, the mean absolute relative difference being less than the second mean absolute relative difference.
Dependencies are inferred from the claim text.